Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Samrat Pharmachem's operating assets for the quarter that ended in Jun. 2026 was ₹0 Mil. Samrat Pharmachem's operating liabilities for the quarter that ended in Jun. 2026 was ₹0 Mil. Samrat Pharmachem's Total Assets for the quarter that ended in Mar. 2026 was ₹1,244 Mil. Therefore, Samrat Pharmachem's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2026 was 0.00.
Samrat Pharmachem Scaled Net Operating Assets Related Terms
Samrat Pharmachem Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Samrat Pharmachem's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Samrat Pharmachem Scaled Net Operating Assets Chart
BOM:530125 vs DOW: Scaled Net Operating Assets Comparison
For the Chemicals subindustry, Samrat Pharmachem's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Samrat Pharmachem Scaled Net Operating Assets vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Samrat Pharmachem's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Samrat Pharmachem's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.00 mean?
Samrat Pharmachem (BOM:530125) has a Scaled Net Operating Assets of 0.00 as of Jun. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Samrat Pharmachem and its competitors.
Is Samrat Pharmachem's Scaled Net Operating Assets too high?
Samrat Pharmachem's current Scaled Net Operating Assets is 0.00. Overall, Samrat Pharmachem has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Samrat Pharmachem's Scaled Net Operating Assets compare to DOW?
Samrat Pharmachem's Scaled Net Operating Assets of 0.00 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Chemicals company?
A good Scaled Net Operating Assets depends on the Chemicals industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Samrat Pharmachem and its competitors. Samrat Pharmachem's current Scaled Net Operating Assets is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Samrat Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Samrat Pharmachem (BOM:530125) is currently considered Possible Value Trap. The stock's GF Value™ is ₹355.51, compared to a current price of ₹227.15 — trading 36.1% below its estimated fair value. The current Scaled Net Operating Assets is 0.00. Samrat Pharmachem's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Samrat Pharmachem (BOM:530125), the current Scaled Net Operating Assets is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Samrat Pharmachem (BOM:530125) Overvalued in 2026?
Based on GuruFocus' analysis, Samrat Pharmachem stock appears to be undervalued.
The current stock price of ₹227.15 is trading 36.1% below its estimated GF Value™ of ₹355.51.
GuruFocus considers Samrat Pharmachem to be Possible Value Trap.
Key valuation signals for BOM:530125:
Scaled Net Operating Assets: 0.00
GF Value™: ₹355.51 vs. price of ₹227.15 (36.1% below fair value)
No single metric tells the full story. See the BOM:530125 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Samrat Pharmachem Ltd is a producer of pharmaceutical chemicals. The principal activity of the company is to manufacture Iodine salts and bromine salts. Its product portfolio consists of potassium iodate, potassium iodide, methyl iodide, and copper iodide. Its products are used in various industries like pharmaceuticals and chemicals.
62GF Score
Get the complete analysis for BOM:530125
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530125 has been successfully added to your 
